Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity

Arik H. O., Yalcin A. D., Celik B., Seyman D., Tetik G., Gursoy B., ...More

MEDICAL SCIENCE MONITOR, vol.20, pp.1078-1081, 2014 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 20
  • Publication Date: 2014
  • Doi Number: 10.1265/msm.890517
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1078-1081
  • Keywords: Biological Markers - analysis, Biological Markers - chemistry, Diabetic Foot - blood, Diabetic Nephropathies - blood, Diabetic Nephropathies - diagnosis, Diabetic Nephropathies - immunology, 25-HYDROXYVITAMIN D, MANAGEMENT, SCD200, OMALIZUMAB, IL-1-BETA, SEVERITY, STRAIL
  • Akdeniz University Affiliated: Yes


Background: CD200 (OX-2) is a novel immune-effective molecule, existing in a cell membrane-bound form, as well as in a soluble form in serum (s OX-2), which acts to regulate inflammatory and acquired immune responses.